| Resource Base Limited (RBX) ORDINARY FULLY PAID |
Materials |
$5 |
Tenements prospective for Gold, Titanium and REEs granted
|
28 Apr 2025 9:22AM |
$0.030 |
$0.041 |
risen by
36.67%
|
|
RBX - Price-sensitive ASX Announcement
Full Release
Key Points
- Resource Base Limited (RBX) granted tenements prospective for gold, titanium, and REEs in the Northern Territory.
- Tenements are situated in the highly prospective Pine Creek Orogen.
- Area is historically significant for gold and emerging for titanium and REE resources.
- Region is underexplored and benefits from nearby infrastructure and favorable regulatory conditions.
- Historical data and previous exploration indicate encouraging mineralization for gold, titanium, and REEs.
- RBX plans systematic exploration programs to assess and advance the project.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Energy Resources of Australia Limited (ERA) ORDINARY FULLY PAID 'A' |
Energy |
$1,622 |
Quarterly Activities Report
|
28 Apr 2025 9:20AM |
$0.002 |
$0.004 |
risen by
100%
|
|
ERA - Price-sensitive ASX Announcement
Full Release
Key Points
- ERA continued rehabilitation activities at the Ranger Project Area, focusing on landform shaping and tailings transfer.
- Significant progress was made in capping activities and water treatment procedures.
- The feasibility study for the final rehabilitation project is ongoing, with expected completion in the first half of 2024.
- Stakeholder and Traditional Owner engagement remained a priority, with regular meetings and updates provided.
- Financial review noted the need for additional funding to complete the rehabilitation project beyond 2024.
- ERA reported no significant safety incidents during the quarter and maintained a focus on safety culture.
- The company remains committed to regulatory compliance and environmental stewardship.
- Engagement with the Commonwealth and Northern Territory governments continued regarding ongoing approvals and funding matters.
- ERA held sufficient cash resources as at 30 September 2023, but further funding will be required.
- The report reiterates ERA’s dedication to achieving a world-class standard in mine site rehabilitation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Graincorp Limited (GNC) ORDINARY FULLY PAID CLASS A |
Consumer Staple |
$1,443 |
Update - Notification of buy-back - GNC
|
28 Apr 2025 9:20AM |
$6.610 |
$6.490 |
fallen by
1.82%
|
|
| Morphic Ethical Equities Fund Limited (MEC) ORDINARY FULLY PAID |
Financials |
$37 |
Update - Notification of buy-back - MEC
|
28 Apr 2025 9:19AM |
$1.000 |
$1.210 |
risen by
21%
|
|
| BTC Health Ltd (BTC) ORDINARY FULLY PAID |
Financials |
$19 |
Net Tangible Asset Backing - 31 March 2025
|
28 Apr 2025 9:19AM |
$0.050 |
$0.054 |
risen by
8%
|
|
| Sparc Technologies Limited (SPN) ORDINARY FULLY PAID |
Materials |
$38 |
Successful ecosparc Field Trial Results
|
28 Apr 2025 9:18AM |
$0.170 |
$0.325 |
risen by
91.18%
|
|
SPN - Price-sensitive ASX Announcement
Full Release
Key Points
- Sparc Technologies Limited announced successful ecosparc® field trial results.
- Field trial was conducted at the Port of Esperance iron ore loading facility.
- ecosparc® demonstrated significant dust suppression performance.
- Results highlighted operational, environmental, and health benefits.
- Project was a collaboration with Strategic Port Holdings (SPH) and Southern Ports.
- Successful outcomes position ecosparc® for further commercialisation.
- ecosparc® offers market opportunities in bulk material handling industries.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lodestar Minerals Limited (LSR) ORDINARY FULLY PAID |
Materials |
$23 |
Retraction and JORC Code table
|
28 Apr 2025 9:18AM |
$0.017 |
$0.020 |
risen by
17.65%
|
|
LSR - Price-sensitive ASX Announcement
Full Release
Key Points
- Lodestar Minerals Limited released a retraction and clarification concerning previously reported exploration results.
- The announcement addresses compliance gaps with the JORC Code, particularly in providing sufficient context and supporting data.
- A full, corrected JORC Code Table 1 is included, detailing the procedures and quality controls applied in the company's exploration work.
- The table covers aspects such as sampling techniques, data verification, site location accuracy, and reporting methodology.
- Lodestar reinforces its commitment to transparent disclosure and rectifies earlier omissions or incomplete reporting.
- This move aims to align all future disclosures with industry standards and regulatory expectations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| VGI Partners Global Investments Limited (VG1) ORDINARY FULLY PAID |
Financials |
- |
Update - Notification of buy-back - VG1
|
28 Apr 2025 9:18AM |
$1.525 |
$1.950 |
risen by
27.87%
|
|
| IPH Limited (IPH) ORDINARY FULLY PAID |
Industrials |
$916 |
Update - Notification of buy-back - IPH
|
28 Apr 2025 9:17AM |
$4.500 |
$3.500 |
fallen by
22.22%
|
|
| Australian Clinical Labs Limited (ACL) ORDINARY FULLY PAID |
Health Care |
$391 |
Update - Notification of buy-back - ACL
|
28 Apr 2025 9:17AM |
$3.010 |
$2.080 |
fallen by
30.90%
|
|
| Bubalus Resources Limited (BUS) ORDINARY FULLY PAID |
Materials |
$6 |
Drilling Commences at Crosbie South Gold Project
|
28 Apr 2025 9:17AM |
$0.160 |
$0.081 |
fallen by
49.38%
|
|
BUS - Price-sensitive ASX Announcement
Full Release
Key Points
- Bubalus Resources Limited begins drilling at Crosbie South Gold Project in Newfoundland.
- The project targets high-priority gold anomalies identified through earlier exploration activities.
- Drilling program is designed to test significant geochemical and structural gold targets.
- The project is situated in a geologically prospective region known for gold mineralization.
- Bubalus employs a systematic exploration approach involving detailed planning and target generation.
- Commitment to safety, environmental responsibility, and strong community engagement is emphasized.
- The company's strategy aims to create value through exploration in underexplored gold districts.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Worley Limited (WOR) ORDINARY FULLY PAID |
Industrials |
$5,751 |
Update - Notification of buy-back - WOR
|
28 Apr 2025 9:16AM |
$12.170 |
$11.660 |
fallen by
4.19%
|
|
| Australian Foundation Investment Company Limited (AFI) ORDINARY FULLY PAID |
Financials |
$8,370 |
Letter to Shareholders - Shareholder Information Meetings
|
28 Apr 2025 9:16AM |
$7.130 |
$6.680 |
fallen by
6.31%
|
|
| Diversified United Investment Limited (DUI) ORDINARY FULLY PAID |
Financials |
$1,091 |
Update - Notification of buy-back - DUI
|
28 Apr 2025 9:16AM |
$5.080 |
$5.080 |
fallen by
0%
|
|
| Switzer Dividend Growth Fund (Managed Fund) (SWTZ) |
Financials |
$59 |
Distribution for month ending 30 April 2025
|
28 Apr 2025 9:15AM |
$2.320 |
$2.520 |
risen by
8.62%
|
|
| CGN Resources Limited (CGR) ORDINARY FULLY PAID |
Materials |
$8 |
Drilling Commences at Webb Project
|
28 Apr 2025 9:14AM |
$0.090 |
$0.074 |
fallen by
17.78%
|
|
| Orora Limited (ORA) ORDINARY FULLY PAID |
Materials |
$1,801 |
Update - Notification of buy-back - ORA
|
28 Apr 2025 9:14AM |
$1.795 |
$1.470 |
fallen by
18.11%
|
|
| Region Group (RGN) FULLY PAID UNITS STAPLED SECURITIES |
Real Estate |
$2,632 |
Update - Notification of buy-back - RGN
|
28 Apr 2025 9:13AM |
$2.280 |
$2.290 |
risen by
0.44%
|
|
| Mirrabooka Investments Limited (MIR) ORDINARY FULLY PAID |
Financials |
$589 |
Letter to Shareholders - Shareholder Information Meetings
|
28 Apr 2025 9:13AM |
$3.220 |
$2.630 |
fallen by
18.32%
|
|
| Djerriwarrh Investments Limited (DJW) ORDINARY FULLY PAID |
Financials |
$757 |
Letter to Shareholders - Shareholder Information Meetings
|
28 Apr 2025 9:13AM |
$3.020 |
$2.880 |
fallen by
4.64%
|
|
| Bathurst Resources Limited (BRL) ORDINARY FULLY PAID |
Materials |
$137 |
Application for quotation of securities - BRL
|
28 Apr 2025 9:13AM |
$0.740 |
$0.570 |
fallen by
22.97%
|
|
| Iron Road Limited (IRD) ORDINARY FULLY PAID |
Materials |
$14 |
Update - Notification of buy-back - IRD
|
28 Apr 2025 9:12AM |
$0.042 |
$0.017 |
fallen by
59.52%
|
|
| Bubs Australia Limited (BUB) ORDINARY FULLY PAID |
Consumer Staple |
$98 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
28 Apr 2025 9:12AM |
$0.120 |
$0.110 |
fallen by
8.33%
|
|
BUB - Price-sensitive ASX Announcement
Full Release
Key Points
- Gross revenue for Q3 FY24 increased by 45% to $22.4 million compared to the prior quarter.
- Bubs' revenue from China grew by 77% quarter-on-quarter due to cross-border e-commerce channel realignment.
- The US business saw a 27% quarter-on-quarter increase in gross revenue, driven by FDA approval for 15 Bubs and Aussie Bubs infant formula products and expanded retail distribution.
- Australian domestic revenue declined, mainly due to the exit from Daigou and Chemist Warehouse channels.
- The company completed a strategic review, focusing on core international markets and cost efficiencies.
- Net cash inflow from operating activities was $5.7 million for the quarter, with an ending cash balance of $27.4 million.
- Inventory reduced by $4.8 million as part of working capital management initiatives.
- Bubs invested in marketing to support China and US growth, with $3.1 million spent during the quarter.
- No government grants or other external financing received during the quarter.
- The Board and management remain focused on sustainable growth, profitability, and cost discipline.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Waratah Minerals Limited (WTM) ORDINARY FULLY PAID |
Materials |
$233 |
Drilling Extends Spur Gold Corridor
|
28 Apr 2025 9:11AM |
$0.190 |
$0.750 |
risen by
294.74%
|
|
WTM - Price-sensitive ASX Announcement
Full Release
Key Points
- Successful extension of the Spur Gold Corridor at the Spur Project through recent drilling.
- Drilling confirmed significant gold mineralization with multiple high-grade intercepts.
- The gold system has been expanded both laterally and at depth.
- Mineralization remains open in several directions, indicating further exploration potential.
- Follow-up drilling is planned to extend and infill resource areas.
- Results reinforce the Spur Gold Corridor as a core asset for Waratah Minerals Limited.
- Company intends to continue aggressive exploration and resource delineation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Neurizon Therapeutics Limited (NUZ) ORDINARY FULLY PAID |
Health Care |
$61 |
Appendix 4C & Quarterly Update
|
28 Apr 2025 9:11AM |
$0.120 |
$0.086 |
fallen by
28.33%
|
|
NUZ - Price-sensitive ASX Announcement
Full Release
Key Points
- Neurizon Therapeutics Limited (NUZ) published its Appendix 4C and Quarterly Update for the quarter ending March 31, 2024.
- The company advanced its NRX-101 Phase 2b/3 clinical trial, recruiting patients and progressing towards key clinical milestones.
- Ongoing development of additional pipeline assets, NRX-102 and NRX-103, continues.
- Active engagement with the US FDA regarding clinical programs and regulatory pathways.
- NUZ is pursuing business development opportunities, including potential partnerships and collaborations.
- The company reported a cash position sufficient to support ongoing clinical development and operations.
- Expenditure for the quarter was provided, with details on research, administrative, and operational costs.
- NUZ remains focused on its mission to develop therapies for unmet needs in neuropsychiatric and neurological disorders.
- The report outlines anticipated upcoming milestones and future financial runway.
- No dividends or payments to related parties were made during the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
